Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$235.0M
+18.0% from 2023
Prescriptions
16K
$15,137.64 per claim
Patients
1,980
2,023 prescribers
Total spending, 2024
$235.3M
$118,784.36 per patient
Medicare prescription drug plans paid $235.0M for Bosulif in 2024, for 15,525 prescriptions and refills to 1,980 patients (up 18.0% from 2023). The average cost per claim was $15,137.64.
Florida had the highest Medicare cost for Bosulif in 2024: $21.6M for 1,399 claims, followed by California ($19.8M).
James E Thompson, hematology in Buffalo, NY, had the highest Medicare cost for Bosulif in 2024: 80 claims costing $856K.
Bosulif is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm, Pfizer Labs..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| James E Thompson Buffalo, NY | Hematology | 80 | Under 11 | $856K |
| Lisa Reale Miami, FL | Hematology-Oncology | 55 | Under 11 | $836K |
| Luis G Rangel Hialeah, FL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,703 | 12,137 | 1,628 | $170.0M |
| 2023 | 1,763 | 12,954 | 1,731 | $199.1M |
| 2024 | 2,023 | 15,525 | 1,980 | $235.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 53 |
| Under 11 |
| $825K |
| Robert F Manges Fort Wayne, IN | Medical Oncology | 45 | Under 11 | $737K |
| Krishnamohan R Basarakodu Dothan, AL | Medical Oncology | 36 | Under 11 | $734K |
| Sean P Goonan Rochester, NY | Nurse Practitioner | 58 | Under 11 | $726K |
| James I Weitzman Boston, MA | Hematology-Oncology | 37 | Under 11 | $714K |
| Kristen M Kindervater Ann Arbor, MI | Physician Assistant | 65 | Under 11 | $660K |
| Stephanie B Tsai Maywood, IL | Internal Medicine | 36 | Under 11 | $658K |
| Lori J Maness-Harris Omaha, NE | Hematology | 44 | Under 11 | $637K |
| Theresa Nguyen Boston, MA | Nurse Practitioner | 55 | Under 11 | $634K |
| Nikolai A Podoltsev New Haven, CT | Medical Oncology | 45 | Under 11 | $634K |
| Fevzi F Yalniz Lexington, KY | Hematology | 33 | Under 11 | $630K |
| Robert H Collins Jr. Dallas, TX | Hematopoietic Cell Transplantation and Cellular Therapy | 33 | Under 11 | $614K |
| Tiffany N Tanaka San Diego, CA | Hematology-Oncology | 37 | Under 11 | $612K |
| Seaborn M Wade III Mechanicsville, VA | Hematology-Oncology | 32 | Under 11 | $598K |
| Heather M Fox Ann Arbor, MI | Physician Assistant | 33 | Under 11 | $589K |
| Jennifer P Brow Fort Wayne, IN | Hematology-Oncology | 36 | Under 11 | $581K |
| Jon Fukumoto Honolulu, HI | Hematology | 50 | Under 11 | $581K |
| Lisa A Nodzon Tampa, FL | Nurse Practitioner | 33 | Under 11 | $571K |
| Brad P Baltz Little Rock, AR | Hematology-Oncology | 29 | Under 11 | $563K |
| Robert E Reynolds Oklahoma City, OK | Medical Oncology | 34 | Under 11 | $556K |
| Samantha Salvatora Houston, TX | Physician Assistant | 41 | Under 11 | $550K |
| Danielle Blake Detroit, MI | Nurse Practitioner | 51 | Under 11 | $550K |
| Pavan S Reddy Wichita, KS | Hematology-Oncology | 25 | Under 11 | $535K |
Spending by manufacturer as listed in the spending data